20 reports

  • Sensorion Raises USD9 Million in IPO
  • Apr 13, 2017: SENSORION: Intensification of the Company's International Development with the Appointment of a New CEO

Sensorion remains focused on becoming a global leader in the treatment of inner ear diseases.

  • Ear Disease
  • Pharmaceutical
  • Therapy
  • France
  • Sensorion S.A.

FEB ##, 2017: SENSORION INNER EAR DISEASE PRODUCT CANDIDATES AND TECHNOLOGY SUBJECT OF MULTIPLE PRESENTATIONS AT ARO MIDWINTER MEETING 2017 Sensorion, a biotech company specializing in the treatment of inner ear diseases, provided details of the podium and poster

  • Ear Disease
  • Ear, Nose, And Throat Medicine
  • Europe
  • Product Initiative
  • Sensorion S.A.
  • Sound Pharmaceuticals Inc
  • QPHL-2 - Drug Profile

Meniere disease is a disorder of the inner ear that causes spontaneous episodes of vertigo.

  • Ear Disease
  • Pathology
  • Therapy
  • United States
  • Otonomy, Inc.
  • 1.1 Hearing Loss

Causes of Hearing Loss: ##. ## Hearing Loss Diagnosis of Hearing Loss: There are certain tests to diagnose hearing loss in a person that include: Malformation of outer ear, ear canal or middle ear structure Ear infection Allergies Benign tumors Impacted earwax Exposu

  • Ear Disease
  • World
  • Forecast
  • Market Size
  • Sonova Holding AG
  • Clinical Trial profile. 31 Trial Title
  • Clinical Trial Profile Snapshots
  • Ear Disease
  • Hospital
  • Pathology
  • World
  • Product Initiative
  • Clinical Trial profile. 35 Trial Title
  • LATEST CLINICAL TRIALS NEWS ON HEARING DISORDERS
  • Clinical Trial
  • Ear Disease
  • Hospital
  • World
  • Product Initiative
  • FEATURED NEWS & PRESS RELEASES

These highly ototoxic medications can result in permanent, and often progressive inner ear disease.

  • Ear Disease
  • Therapy
  • United States
  • Product Initiative
  • Auris Medical Holding AG
  • FEATURED NEWS & PRESS RELEASES

These highly ototoxic medications can result in permanent, and often progressive inner ear disease.

  • Ear Disease
  • Pathology
  • United States
  • Product Initiative
  • Auris Medical Holding AG
  • Clinical Trial profile. 85 Trial Title
  • Latest Clinical Trials News on Otitis Media

Otonomy, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, announced the enrollment of the first patients in a Phase ## clinical trial evaluating a single administration of OTIPRIO™ (c

  • Drug Discovery And Development
  • Ear Disease
  • Hospital
  • World
  • Product Initiative
  • Trial Results
  • Five Key Clinical Profiles
  • Ear Disease
  • Therapy
  • World
  • Auris Medical Holding AG
  • Pfizer Inc.
  • R&D Progress
  • R&D Progress

THE INVENTION RELATES TO METHODS AND KITS USEFUL FOR PROVIDING NEUROPROTECTION TO NEURONS IN THE INNER EAR AND TO METHODS OF TREATING INNER EAR DISEASES AND DISORDERS, INCLUDING TINNITUS AND MENIERE' S DISEASE.

  • Ear Disease
  • United States
  • World
  • Product Initiative
  • Quark
  • VENTURE FINANCING
  • Jan 05, 2016: FDA allows Sound Pharmaceuticals to begin Meniere Disease clinical trial
  • Ear Disease
  • United States
  • Company
  • Deals & Alliance
  • GlobalData's company

MENIERE' S DISEASE HAS NO FDA APPROVED PRODUCTS, AND IS OFTEN MANAGED WITH DIET, DIURETICS AND STEROIDS, WHICH ARE NOT DISEASE MODIFYING.

  • Ear Disease
  • United States
  • Company
  • Company Financials
  • GlobalData's company
  • Sound Pharmaceuticals Inc
  • QPHL-2 - Drug Profile

Meniere disease is a disorder of the inner ear that causes spontaneous episodes of vertigo.

  • Ear Disease
  • Pathology
  • Therapy
  • United States
  • Otonomy, Inc.
  • OR-102 - DRUG PROFILE

It was also under development for the treatment of myocardial infarction, organ transplantation, Meniere disease and Parkinson' s disease (cell transplantation).

  • Ear Disease
  • Pathology
  • World
  • Product Initiative
  • Auris Medical Holding AG
  • Clinical Trial profile. 20 Trial Title
  • Clinical Trial Profile Snapshots

PHASE II TRIALS: Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks.

  • Ear Disease
  • Hospital
  • World
  • Product Initiative
  • Auris Medical Holding AG
  • Palau Pharma, S.A.
  • Ear Disease
  • In Vitro Diagnostics
  • Molecular Diagnostic
  • World
  • Product Initiative
  • Five Key Clinical Profiles

THE DRUG CANDIDATE BY INHIBITING THE ACTIVITY OF THESES ENZYMES CHECKS THE UNDERLYING CAUSE OF DISEASE.

  • Drug Discovery And Development
  • Ear Disease
  • Therapy
  • World
  • Product Initiative
  • MENIERE DISEASE

In many cases, Meniere disease affects only one ear.

  • Clinical Trial
  • Drug Discovery And Development
  • Ear Disease
  • World
  • Otonomy, Inc.
  • EXAMPLES OF OUTER, MIDDLE AND INNER EAR DISEASES
  • DRUGS FOR INNER EAR DISEASES: RESEARCH PIPELINE AT UNIVERSITIES
  • Ear Disease
  • United States
  • AudioCure Pharma GmbH
  • Autifony Therapeutics Limited
  • Cochlear Limited